C
Chuanlai Xu
Researcher at Jiangnan University
Publications - 729
Citations - 22485
Chuanlai Xu is an academic researcher from Jiangnan University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 64, co-authored 439 publications receiving 16164 citations.
Papers
More filters
Journal ArticleDOI
The Construction and Development of a Clinical Prediction Model to Assess Lymph Node Metastases in Osteosarcoma
Wenle Li,Sheng-jian Dong,Bing Wang,Haosheng Wang,Chuanlai Xu,Kai Zhang,Wanying Li,Zhao-hui Hu,Xiao-Peng Li,Qiang Liu,Rilige Wu,Chengliang Yin +11 more
TL;DR: A nomogram with risk factors is constructed and developed, which performed well in predicting risk factors of LNM in osteosarcoma patients, which may give a guide for surgeons and oncologists to optimize individual treatment and make a better clinical decision.
Journal ArticleDOI
Chirality at nanoscale for bioscience
TL;DR: The principles of organization underlying chiral nanomaterials are summarized and generalize the recent advances in the main strategies used to fabricate these nanoparticles for bioscience applications are generalized.
Journal ArticleDOI
Visible and eco-friendly immunoassays for the detection of cyclopiazonic acid in maize and rice
TL;DR: The eco-friendly immunoassays, including an indirect competitive enzyme-linked immunosorbent assay (ic-ELISA) and a lateral flow immunochromatographic strip (LFICS), were developed to monitor CPA in maize and rice samples providing an auxiliary analytical tool for the rapid, sensitive, and portable screening of the massive samples onsite.
Journal ArticleDOI
Preparation of an anti-isoprocarb monoclonal antibody and its application in developing an immunochromatographic strip assay.
TL;DR: Both methods met the requirements for isoprocarb residue detection in agricultural products, and can be used for semi-quantitative and qualitative analysis of isopocarb in vegetables.
Journal ArticleDOI
Rapid colloidal gold immunochromatographic assay for the detection of SARS-CoV-2 total antibodies after vaccination.
TL;DR: The convenient and rapid GICA method was found to have high sensitivity and specificity and could preliminarily evaluate the protection rate and effectiveness of vaccines by monitoring total antibody levels.